260 related articles for article (PubMed ID: 25226504)
1. The sensitivity of cancer cells to pheophorbide a-based photodynamic therapy is enhanced by Nrf2 silencing.
Choi BH; Ryoo IG; Kang HC; Kwak MK
PLoS One; 2014; 9(9):e107158. PubMed ID: 25226504
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the Effect of Methyl Pyropheophorbide-a-Mediated Photodynamic Therapy was Achieved by Increasing ROS through Inhibition of Nrf2-HO-1 or Nrf2-ABCG2 Signaling.
Tian S; Yong M; Zhu J; Zhang L; Pan L; Chen Q; Li KT; Kong YH; Jiang Y; Yu TH; Yu LH; Bai DQ
Anticancer Agents Med Chem; 2017; 17(13):1824-1836. PubMed ID: 28356018
[TBL] [Abstract][Full Text] [Related]
3. The c-MET/PI3K signaling is associated with cancer resistance to doxorubicin and photodynamic therapy by elevating BCRP/ABCG2 expression.
Jung KA; Choi BH; Kwak MK
Mol Pharmacol; 2015; 87(3):465-76. PubMed ID: 25534417
[TBL] [Abstract][Full Text] [Related]
4. Role of Nrf2 in cancer photodynamic therapy: regulation of human ABC transporter ABCG2.
Ishikawa T; Kajimoto Y; Sun W; Nakagawa H; Inoue Y; Ikegami Y; Miyatake S; Kuroiwa T
J Pharm Sci; 2013 Sep; 102(9):3058-69. PubMed ID: 23650051
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of caveolin-1 decreases activity of breast cancer resistance protein (BCRP/ABCG2) and increases chemotherapeutic sensitivity.
Herzog M; Storch CH; Gut P; Kotlyar D; Füllekrug J; Ehehalt R; Haefeli WE; Weiss J
Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan; 383(1):1-11. PubMed ID: 20936466
[TBL] [Abstract][Full Text] [Related]
6. Nrf2-dependent induction of human ABC transporter ABCG2 and heme oxygenase-1 in HepG2 cells by photoactivation of porphyrins: biochemical implications for cancer cell response to photodynamic therapy.
Hagiya Y; Adachi T; Ogura S; An R; Tamura A; Nakagawa H; Okura I; Mochizuki T; Ishikawa T
J Exp Ther Oncol; 2008; 7(2):153-67. PubMed ID: 18771089
[TBL] [Abstract][Full Text] [Related]
7. Enhanced efficacy of photodynamic therapy by inhibiting ABCG2 in colon cancers.
Kim JH; Park JM; Roh YJ; Kim IW; Hasan T; Choi MG
BMC Cancer; 2015 Jul; 15():504. PubMed ID: 26149077
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer resistance protein is the enemy of hypericin accumulation and toxicity of hypericin-mediated photodynamic therapy.
Jendželovský R; Jendželovská Z; Kuchárová B; Fedoročko P
Biomed Pharmacother; 2019 Jan; 109():2173-2181. PubMed ID: 30551474
[TBL] [Abstract][Full Text] [Related]
9. Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.
Singh A; Wu H; Zhang P; Happel C; Ma J; Biswal S
Mol Cancer Ther; 2010 Aug; 9(8):2365-76. PubMed ID: 20682644
[TBL] [Abstract][Full Text] [Related]
10. ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy.
Robey RW; Steadman K; Polgar O; Bates SE
Cancer Biol Ther; 2005 Feb; 4(2):187-94. PubMed ID: 15684613
[TBL] [Abstract][Full Text] [Related]
11. Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells.
Jendzelovský R; Mikes J; Koval' J; Soucek K; Procházková J; Kello M; Sacková V; Hofmanová J; Kozubík A; Fedorocko P
Photochem Photobiol Sci; 2009 Dec; 8(12):1716-23. PubMed ID: 20024169
[TBL] [Abstract][Full Text] [Related]
12. Critical role of ABCG2 in ALA-photodynamic diagnosis and therapy of human brain tumor.
Ishikawa T; Kajimoto Y; Inoue Y; Ikegami Y; Kuroiwa T
Adv Cancer Res; 2015; 125():197-216. PubMed ID: 25640271
[TBL] [Abstract][Full Text] [Related]
13. Use of baculovirus BacMam vectors for expression of ABC drug transporters in mammalian cells.
Shukla S; Schwartz C; Kapoor K; Kouanda A; Ambudkar SV
Drug Metab Dispos; 2012 Feb; 40(2):304-12. PubMed ID: 22041108
[TBL] [Abstract][Full Text] [Related]
14. Role of NF-κB/Snail/RKIP loop in the response of tumor cells to photodynamic therapy.
Rapozzi V; Umezawa K; Xodo LE
Lasers Surg Med; 2011 Sep; 43(7):575-85. PubMed ID: 22057485
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy inhibits P-glycoprotein mediated multidrug resistance via JNK activation in human hepatocellular carcinoma using the photosensitizer pheophorbide a.
Tang PM; Zhang DM; Xuan NH; Tsui SK; Waye MM; Kong SK; Fong WP; Fung KP
Mol Cancer; 2009 Jul; 8():56. PubMed ID: 19646254
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer.
Usuda J; Tsunoda Y; Ichinose S; Ishizumi T; Ohtani K; Maehara S; Ono S; Tsutsui H; Ohira T; Okunaka T; Furukawa K; Sugimoto Y; Kato H; Ikeda N
Lung Cancer; 2010 Feb; 67(2):198-204. PubMed ID: 19477032
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer resistance protein (BCRP/ABCG2) localises to the nucleus in glioblastoma multiforme cells.
Bhatia P; Bernier M; Sanghvi M; Moaddel R; Schwarting R; Ramamoorthy A; Wainer IW
Xenobiotica; 2012 Aug; 42(8):748-55. PubMed ID: 22401348
[TBL] [Abstract][Full Text] [Related]
18. The Cisplatin-Derived Increase of Mitochondrial Reactive Oxygen Species Enhances the Effectiveness of Photodynamic Therapy via Transporter Regulation.
Kurokawa H; Ito H; Matsui H
Cells; 2019 Aug; 8(8):. PubMed ID: 31426474
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2.
Imai Y; Ishikawa E; Asada S; Sugimoto Y
Cancer Res; 2005 Jan; 65(2):596-604. PubMed ID: 15695404
[TBL] [Abstract][Full Text] [Related]
20. Evidence that photoactivated pheophorbide a causes in human cancer cells a photodynamic effect involving lipid peroxidation.
Rapozzi V; Miculan M; Xodo LE
Cancer Biol Ther; 2009 Jul; 8(14):1318-27. PubMed ID: 19421008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]